ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2025

Comparison of Effects of Glucagon-Like Peptide-1 Receptor Agonists Compared to Long-Acting Insulin, Added to Oral Anti-Diabetic Agents on Self-Management Behaviors, Anxiety, and Sleep Quality in Patients with Type 2 Diabetes.

Xiaoqing Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.